After the surgeon has removed the testicle (orchidectomy) the tissue is examined under a microscope. This will find out the type of testicular cancer you have.
Most testicular cancers develop from germ cells in the testicles, so they are also called germ cell tumours (GCTs). Germ cells in the testicles produce sperm. The term testicular cancer is for all types of testicular tumour.
There are two main types of testicular germ cell cancer:
Seminomas usually happen between the ages of 15 to 55. About 40 to 45 in 100 (40 to 45%) of testicular cancer are a seminoma.
Non-seminomas most often affect people aged 15 to 35. About 40 to 45 in 100 (40 to 45%) of testicular cancers are non-seminomas.
Non-seminomas are made of different types of cells. They can be made of just one cell type, or they may be made of a mixture. They include:
- embryonal tumours
- yolk sac tumours
Sometimes, non-seminomas can be combined with seminomas.
We have more information about testicular cancer treatment.
Below is a sample of the sources used in our testicular cancer information. If you would like more information about the sources we use, please contact us at email@example.com
European Association of Urology. Guidelines on Cancer. 2016. Available from: www.baus.org.uk/_userfiles/pages/files/professionals/sections/oncology/EAU2015-Testicular-Cancer.pdf (accessed August 2018)
European Society for Medical Oncology, eUpdate. Testicular Seminoma and Non-Seminoma Treatment Recommendations. June 2017. Available from: www.esmo.org/Guidelines/Genitourinary-Cancers/Testicular-Seminoma-and-Non-Seminoma/eUpdate-Treatment-Recommendation (accessed August 2018).
Scottish Intercollegiate Guidelines Network, Management of adult testicular germ cell tumours. Available from: www.sign.ac.uk/sign-124-management-of-adult-testicular-germ-cell-tumours.html (accessed August 2018).
UpToDate. Clinical manifestations, diagnosis, and staging of testicular germ cell tumors. January 2018. Available from: www.uptodate.com/contents/clinical-manifestations-diagnosis-and-staging-of-testicular-germ-cell-tumors (accessed August 2018).
This information has been written, revised and edited by Macmillan Cancer Support’s Cancer Information Development team. It has been reviewed by expert medical and health professionals and people living with cancer. It has been approved by Senior Medical Editor, Dr Jim Barber, Consultant Clinical Oncologist.
Our cancer information has been awarded the PIF TICK. Created by the Patient Information Forum, this quality mark shows we meet PIF’s 10 criteria for trustworthy health information.
Content under review
The language we use
We want everyone affected by cancer to feel our information is written for them.
We try to make sure our information is as clear as possible. We use plain English, avoid jargon, explain any medical words, use illustrations to explain text, and make sure important points are highlighted clearly.
We use gender-inclusive language and talk to our readers as ‘you’ so that everyone feels included. Where clinically necessary we use the terms ‘men’ and ‘women’ or ‘male’ and ‘female’. For example, we do so when talking about parts of the body or mentioning statistics or research about who is affected. Our aims are for our information to be as clear and relevant as possible for everyone.
You can read more about how we produce our information here.